Comorbid conditions in obsessive-compulsive disorder

Comprehensive Psychiatry

Volumn 43, Issue 3, 2002, Pages 204-209

  Tükel, Raşit ^a,b,c   Polat, Aslihan ^a,b,c   OÖzdemir, OÖzay ^a,b,c   Aksuüt, Didem ^a,b,c   Tuürksoy, Nuray ^a,b,c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ACIBADEM HOSPITAL   (Turkey)

^c Bakirkoy Hospital for Psychiatric and Neurological Diseases   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANXIETY NEUROSIS; ARTICLE; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; RISK FACTOR;

EID: 0036249551     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1053/comp.2002.32355     Document Type: Article

References (36)

1. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder
2. The epidemiology of obsessive-compulsive disorder in five U.S. communities
3. The epidemiology and differential diagnosis of obsessive compulsive disorder
4. The epidemiology and clinical features of obsessive compulsive disorder
5. Panic and phobic disorders in patients with obsessive compulsive disorder
6. Obsessive-compulsive disorder and depression
7. Obsessive-compulsive disorder and axis I comorbidity
8. Nosological insertion of axis I disorders in the etiology of obsessive-compulsive disorder
9. Lifetime prevalence of spesific psychiatric disorders in three sites
10. Gender-divergent aetiological factors in obsessive-compulsive disorder
11. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety
12. Obsessive-compulsive disorder and serotonin: Is there a connection?
13. Serotonin function in obsessive-compulsive disorder: A comparison of the effects of tryptophan m-CPP in patients and healthy subjects
14. The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies
15. Neurobiological mechanizms of panic anxiety: Biochemical and behavioral correlates of yohimbine-induced panic attacks
16. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects
17. Panic disorder: The potential role of serotonin reuptake inhibitors
18. OCD: Psychobiological approaches to diagnosis, treatment, and pathophysiology
19. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Comparison of fluvoxamine and desipramine
20. Serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder
21. Current issues in the pharmacologic management of obsessive compulsive disorder
22. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta analysis
23. Patterns of remission and relapse in obsessive-compulsive disorder: A 2-year prospective study
24. The dexamethezone suppression test in patients with primary obsessive compulsive disorder
25. Affective spectrum disorders: Does antidepressant response identify a family of disorders with a common pathophysiology
26. Uncomplicated and comorbid obsessive compulsive disorder in an epidemiologic sample
27. The assessment of anxiety states by rating
28. Development of a rating scale for primary depressive illness
29. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability
30. The Yale-Brown Obsessive Compulsive Scale: II. Validity
31. Obsessive compulsive disorder: Comorbid conditions
32. The cross national epidemiology of obsessive compulsive disorder
33. DSM-IV field trial: Obsessive-compulsive disorder
34. Prevalence of particular obsessions and compulsions in a clinical sample